These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 28394608)

  • 1. Second Generation Triple-Helical Peptide Inhibitors of Matrix Metalloproteinases.
    Bhowmick M; Tokmina-Roszyk D; Onwuha-Ekpete L; Harmon K; Robichaud T; Fuerst R; Stawikowska R; Steffensen B; Roush W; Wong HR; Fields GB
    J Med Chem; 2017 May; 60(9):3814-3827. PubMed ID: 28394608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix Metalloproteinase Triple-Helical Peptide Inhibitors: Potential Cross-Reactivity with Caspase-11.
    Knapinska AM; Hart M; Drotleff G; Fields GB
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31795279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase inhibition by heterotrimeric triple-helical Peptide transition state analogues.
    Bhowmick M; Stawikowska R; Tokmina-Roszyk D; Fields GB
    Chembiochem; 2015 May; 16(7):1084-92. PubMed ID: 25766890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple-helical transition state analogues: a new class of selective matrix metalloproteinase inhibitors.
    Lauer-Fields J; Brew K; Whitehead JK; Li S; Hammer RP; Fields GB
    J Am Chem Soc; 2007 Aug; 129(34):10408-17. PubMed ID: 17672455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of substrate thermal stability and P2 and P1' subsite identity on matrix metalloproteinase triple-helical peptidase activity and collagen specificity.
    Minond D; Lauer-Fields JL; Cudic M; Overall CM; Pei D; Brew K; Visse R; Nagase H; Fields GB
    J Biol Chem; 2006 Dec; 281(50):38302-13. PubMed ID: 17065155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagenolytic Matrix Metalloproteinase Activities toward Peptomeric Triple-Helical Substrates.
    Stawikowski MJ; Stawikowska R; Fields GB
    Biochemistry; 2015 May; 54(19):3110-21. PubMed ID: 25897652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.
    Lauer-Fields JL; Minond D; Chase PS; Baillargeon PE; Saldanha SA; Stawikowska R; Hodder P; Fields GB
    Bioorg Med Chem; 2009 Feb; 17(3):990-1005. PubMed ID: 18358729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New strategies for targeting matrix metalloproteinases.
    Fields GB
    Matrix Biol; 2015; 44-46():239-46. PubMed ID: 25595836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase triple-helical peptidase activities are differentially regulated by substrate stability.
    Minond D; Lauer-Fields JL; Nagase H; Fields GB
    Biochemistry; 2004 Sep; 43(36):11474-81. PubMed ID: 15350133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collagenase-2 deficiency or inhibition impairs experimental autoimmune encephalomyelitis in mice.
    Folgueras AR; Fueyo A; García-Suárez O; Cox J; Astudillo A; Tortorella P; Campestre C; Gutiérrez-Fernández A; Fanjul-Fernández M; Pennington CJ; Edwards DR; Overall CM; López-Otín C
    J Biol Chem; 2008 Apr; 283(14):9465-74. PubMed ID: 18245084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selectivity, binding affinity, and ionization state of matrix metalloproteinase inhibitors.
    Zhong HA; Arbiser J; Bowen JP
    Curr Pharm Des; 2013; 19(26):4701-13. PubMed ID: 23260023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissecting MMP P
    Tokmina-Roszyk M; Fields GB
    J Biol Chem; 2018 Oct; 293(43):16661-16676. PubMed ID: 30185620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of enzyme activity of and cell-mediated substrate cleavage by membrane type 1 matrix metalloproteinase by newly developed mercaptosulphide inhibitors.
    Hurst DR; Schwartz MA; Jin Y; Ghaffari MA; Kozarekar P; Cao J; Sang QX
    Biochem J; 2005 Dec; 392(Pt 3):527-36. PubMed ID: 16026329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic analysis of matrix metalloproteinase activity using fluorogenic triple-helical substrates.
    Lauer-Fields JL; Broder T; Sritharan T; Chung L; Nagase H; Fields GB
    Biochemistry; 2001 May; 40(19):5795-803. PubMed ID: 11341845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of secreted and membrane-type matrix metalloproteinase activities based on substitutions and interruptions of triple-helical sequences.
    Minond D; Lauer-Fields JL; Cudic M; Overall CM; Pei D; Brew K; Moss ML; Fields GB
    Biochemistry; 2007 Mar; 46(12):3724-33. PubMed ID: 17338550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective modulation of matrix metalloproteinase 9 (MMP-9) functions via exosite inhibition.
    Lauer-Fields JL; Whitehead JK; Li S; Hammer RP; Brew K; Fields GB
    J Biol Chem; 2008 Jul; 283(29):20087-95. PubMed ID: 18499673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 1.8-A crystal structure of a matrix metalloproteinase 8-barbiturate inhibitor complex reveals a previously unobserved mechanism for collagenase substrate recognition.
    Brandstetter H; Grams F; Glitz D; Lang A; Huber R; Bode W; Krell HW; Engh RA
    J Biol Chem; 2001 May; 276(20):17405-12. PubMed ID: 11278347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collagen binding properties of the membrane type-1 matrix metalloproteinase (MT1-MMP) hemopexin C domain. The ectodomain of the 44-kDa autocatalytic product of MT1-MMP inhibits cell invasion by disrupting native type I collagen cleavage.
    Tam EM; Wu YI; Butler GS; Stack MS; Overall CM
    J Biol Chem; 2002 Oct; 277(41):39005-14. PubMed ID: 12145314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods for the Construction of Collagen-Based Triple-Helical Peptides Designed as Matrix Metalloproteinase Inhibitors.
    Fields GB
    Methods Mol Biol; 2019; 1944():229-252. PubMed ID: 30840247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Edman degradation sequence analysis and matrix-assisted laser desorption/ionization mass spectrometry in designing substrates for matrix metalloproteinases.
    Lauer-Fields JL; Nagase H; Fields GB
    J Chromatogr A; 2000 Aug; 890(1):117-25. PubMed ID: 10976799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.